Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Avastin (bevacizumab) in combination with mFOLFOX-6 or FOLFOXIRI in metastatic colorectal cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-07